April 4, 2016 / 12:57 PM / a year ago

BRIEF-Health Canada approves Biopharmx's study of violet iodine

1 Min Read

April 4 (Reuters) - Biopharmx Corp

* Health canada approves biopharmx corporation study of violet iodine

* Engages kgk synergize, inc. To manage its canadian phase 4 study for violet molecular iodine breast health supplement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below